Edwards Beats ‘Premature’ $300 Million Suit on Valve Device Deal

Edwards Lifesciences Corp. defeated litigation in Delaware seeking roughly $300 million stemming from its acquisition of a heart valve device, although a judge said similar claims could potentially succeed at a later date.

Judge Meghan A. Adams dismissed the lawsuit by former Valtech Cardio Ltd. investors who said the larger biotech company duped them into deferring up to $350 million of the $690 million sale price when it bought Valtech solely to shelve its Cardioband, which competed with the blockbuster Pascal valve repair platform sold by Edwards.

Because the payments could still come due—there’s a 10-year window for hitting the ...